In a filing, Terns Pharmaceuticals Inc revealed its Director Lu Hongbo acquired Company’s shares for reported $5.0 million on Sep 12 ’24. In the deal valued at $10.50 per share,476,190 shares were bought. As a result of this transaction, Lu Hongbo now holds 476,190 shares worth roughly $2.93 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Vignola Mark J. sold 10,000 shares, generating $110,000 in total proceeds. Upon selling the shares at $11.00, the Chief Financial Officer now owns 91,940 shares.
Before that, Quigley Jill M. sold 17,235 shares. Terns Pharmaceuticals Inc shares valued at $172,350 were divested by the Director at a price of $10.00 per share. As a result of the transaction, Quigley Jill M. now holds 15,000 shares, worth roughly $92250.0.
Oppenheimer initiated its Terns Pharmaceuticals Inc [TERN] rating to an Outperform in a research note published on October 31, 2024; the price target was $82. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in late June with a ‘”a Buy”‘ rating. Jefferies began covering TERN with “Buy” recommendation on June 07, 2023. ROTH MKM started covering the stock on May 31, 2023. It rated TERN as “a Buy”.
Price Performance Review of TERN
On Monday, Terns Pharmaceuticals Inc [NASDAQ:TERN] saw its stock fall -1.44% to $6.15. Over the last five days, the stock has gained 6.22%. Terns Pharmaceuticals Inc shares have fallen nearly -5.24% since the year began. Nevertheless, the stocks have risen 38.20% over the past one year. While a 52-week high of $11.40 was reached on 09/10/24, a 52-week low of $4.19 was recorded on 04/19/24. SMA at 50 days reached $7.24, while 200 days put it at $7.12.
Levels Of Support And Resistance For TERN Stock
The 24-hour chart illustrates a support level at 5.96, which if violated will result in even more drops to 5.77. On the upside, there is a resistance level at 6.35. A further resistance level may holdings at 6.55. The Relative Strength Index (RSI) on the 14-day chart is 42.30, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.67%. Stochastics %K at 36.61% indicates the stock is a holding.
How much short interest is there in Terns Pharmaceuticals Inc?
A steep rise in short interest was recorded in Terns Pharmaceuticals Inc stocks on 2024-11-15, dropping by -0.37 million shares to a total of 3.98 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 4.35 million shares. There was a decline of -9.43%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 08, 2023 when BMO Capital Markets began covering the stock and recommended ‘”an Outperform”‘ rating along with a $18 price target.
